RIP
LLY icon

Reliant Investment Partners’s Eli Lilly LLY Stock Holding History

Reliant Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.89M Sell
3,144
-8
-0.3% -$8.11K 2.4% 8
2025
Q4 		$3.39M Sell
3,152
-13
-0.4% -$12.4K 2.66% 9
2025
Q3 		$2.66M Sell
3,165
-7
-0.2% -$5.21K 2.08% 10
2025
Q2 		$2.47M Sell
3,172
-9
-0.3% -$6.99K 2.16% 11
2025
Q1 		$2.63M Sell
3,181
-26
-0.8% -$21.6K 2.68% 9
2024
Q4 		$2.48M Buy
+3,207
New +$2.66M 2.19% 11

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Reliant Investment Partners's LLY Position: Q1 2026 in Review

Reliant Investment Partners reduced its Eli Lilly (LLY) stake by 0.25% in Q1 2026, selling an estimated $8.11K and leaving 3,144 shares worth $2.89M. The position accounts for 2.4% of the portfolio, ranked #8.

Reliant Investment Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.39M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Reliant Investment Partners held 3,144 shares of Eli Lilly worth $2.89M as of Q1 2026.
  • Reliant Investment Partners sold 8 Eli Lilly shares in Q1 2026, an estimated $8.11K.
  • Eli Lilly made up 2.4% of Reliant Investment Partners's portfolio in Q1 2026, its #8 holding.
  • Reliant Investment Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Reliant Investment Partners's Eli Lilly position peaked at $3.39M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Reliant Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.